Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines
Article content
TORONTO — Breast Cancer Canada proudly celebrates the federal government's response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care.
Article content
'These systematic changes will save lives,' said Kimberly Carson, CEO of Breast Cancer Canada. 'We commend Canada's Federal Health Minister Marjorie Michel for making this a priority so early in her mandate, and we thank former Health Minister Mark Holland for working so closely with Breast Cancer Canada during his tenure. This milestone reflects years of dedicated advocacy. Bringing expert voices into task force decision-making is a long-overdue step toward ensuring that both science and lived experience shape public policy for Canadians.'
The EER outlines recommendations, including stronger integration of subject matter experts, patient and public voices, and structured provincial input in guideline development. For Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance—a national coalition of breast cancer experts—the report validates their persistent calls to reform how health guidance is developed and delivered in Canada. It also affirms that advocacy works: the federal government listened to patients and advocates calling for change.
Article content
This report embodies the transformative shift Breast Cancer Canada has relentlessly advocated for: expert-led, patient-centred, and equity-driven care informed by Canadian data and research. It signals a new era in Canadian breast cancer policy, one grounded in a national commitment to access for all.
Article content
'This report is a breakthrough,' said Kimberly Carson, CEO of Breast Cancer Canada. 'It recognizes that science and lived experience must work together to shape public health guidance. These recommendations reflect what Breast Cancer Canada, researchers, clinicians, and patients have been saying for years.'
Article content
Founded by Breast Cancer Canada in 2023, REAL Canadian Breast Cancer Alliance brings together leading clinicians, patient advocates and data from across the country to advance evidence-based, equitable, and patient-informed breast cancer care. REAL Alliance was established to ensure that the latest research reaches patients faster and to help establish equitable, national standards of care for breast cancer.
Article content
Breast Cancer Canada is actively addressing the critical gap in Canadian-specific data by collecting and analyzing breast cancer outcomes across all stages and subtypes, with a focus on race, age, and geographic location.
Article content
'We are especially encouraged to see a formal shift toward expert engagement,' said Shaniah Leduc, Chair of Breast Cancer Canada's Board of Directors. 'Guidelines that impact patient outcomes must include disease-specific expertise. It's not just about input—it's about equity and access. Science moves quickly, and lives are affected when guidelines lag behind. A commitment to living guidelines ensures Canadians benefit from the most current knowledge in real-time.'
Article content
'As someone whose survival depended on timely diagnosis and access to targeted treatment, I know firsthand the power of evidence-based care,' said Kim MacDonald, breast cancer survivor and advocate with Breast Cancer Canada. 'The recommendations released today are long overdue. Including expert insight and patient experience in national health guidance isn't just the right thing to do—it's what saves lives. My story could have ended differently without access to the testing and treatment I needed. Every Canadian deserves equity and access.'
Article content
As the report notes, current guideline development in Canada is fragmented and often lacks the flexibility to reflect provincial realities or incorporate diverse forms of knowledge. The recommendations call for a pan-Canadian coordination hub and better integration with provincial screening programs, quality councils, and implementation bodies.
Article content
'When evidence, expert insight, and lived experience come together, patients benefit,' Carson added. 'We look forward to seeing these recommendations put into action and continuing our role in ensuring breast cancer care is equitable, evidence-based, and patient-informed.'
Article content
Key Takeaways from the External Expert Review of Canada's Preventive Health Guidelines:
Article content
Structured engagement of patients and community members, particularly from underrepresented groups, to bring real-world lived experience into national guideline development
Article content
Equity-focused topic selection and public accountability, ensuring preventive guidance addresses the realities of all people in Canada, especially those from equity-denied populations
Article content
Contextualizable and coordinated guidelines, enabling provinces and territories to implement evidence-based recommendations in a way that fits their own systems and structures
Article content
A phased transition to living guidelines, so recommendations keep pace with science and practice in real-time
Article content
Breast Cancer Canada remains a committed partner in this modernization effort, with ongoing investments in personalized screening research and the REAL Alliance—a multi-disciplinary expert body established to accelerate breast cancer progress through national collaboration. Breast Cancer Canada is a national charity dedicated to saving lives through science. Focused exclusively on breast cancer research, Breast Cancer Canada funds programs that advance earlier detection, better treatment, and improved outcomes for everyone affected by the disease. For more information, visit breastcancerprogress.ca.
Article content
About Breast Cancer Canada
Article content
Breast Cancer Canada is a national charity focused exclusively on breast cancer research, education, and awareness. Dedicated to advancing science that leads to earlier detection, more precise treatments, improved access to care, and better outcomes, the organization ensures that lived experience is reflected in research priorities. With no government funding, all progress is made possible through the generosity of donors. To learn more, visit breastcancerprogress.ca.
Article content
Article content
Article content
Article content
Contacts
Article content
Media
Article content
Article content
Article content
Article content
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

CTV News
an hour ago
- CTV News
‘We made it': Windsor NICU graduates reunited
The Trella triplets are graduates of the NICU at Windsor Regional Hospital. (Michelle Maluske/CTV Windsor) A reunion for NICU graduates was held Saturday in LaSalle, organized by the parent members of the Windsor Regional Hospital (WRH) Family Advisory Care Team. It's a group of volunteer parents who all had children who needed the neonatal intensive care unit at WRH. Parent chairwoman Michelle Ladouceur's twin daughters were in the NICU for 79 days, eight years ago. Today? 'They are active. They're going into Grade 3 this year, (and) meeting all the great milestones,' Ladouceur said. 'We're so grateful for Windsor Regional (Hospital) NICU to be able to celebrate that success.' 70 graduates of the specialized unit participated in a picnic at the Vollmer Complex. They were treated to snacks, prizes, face-painting, and a chance to ride in a first responder vehicle. Essex-Windsor EMS paramedics joined LaSalle police officers and firefighters for the event. Ladouceur said the event is meant to reunite parents with staff they learned to lean on while in hospital. 'It's completely just about getting together and sharing that learned experience,' Ladouceur said. 'And then, also, just reframing that lens of the experience to say, 'Hey, we made it! We're on the other side.'' WRH's NICU, located at the Metropolitan campus, can care for newborns as young as 26 weeks gestation.


CTV News
an hour ago
- CTV News
‘$135M worth of wasted products': Alberta premier defends decision to charge for COVID vaccines
Alberta Premier Danielle Smith seen in Calgary on Friday, May 16, 2025. (THE CANADIAN PRESS/Jeff McIntosh) Danielle Smith defended her government's decision to charge many Albertans for COVID-19 vaccinations, which the province announced late Friday afternoon in a media release. On her Saturday radio show Your Province, Your Premier, Smith said there's too many wasted and unused vaccines due to low demand. 'The sad part was that we threw away over one million doses (in 2023-24) because people just don't want to get the vaccine in the same rates as others (vaccines),' she said. Smith said the delivery system that was used for COVID vaccines at pharmacies created too many wasted doses. 'They were putting it in packs of 10, so if you opened it up and gave one shot, you had to throw the rest out after 12 hours because it would expire so that's why we ended up with so much wastage,' Smith said. 'And it's not (an) insignificant (amount of money),' she added. 'It was over $100 million – I think $135 million (worth) of wasted products." When one caller chided her for spending money on other things rather than on the health of Albertans, she pushed back. 'I can tell you we could probably end up eliminating the knee and hip-replacement surgical waitlist with (the) $135 million that got flushed down the drain last year (with used or spoiled COVID vaccines). 'We're watching what Albertans are doing and what we're seeing is that Albertans increasingly are choosing not to take this vaccine,' she added. Four phases The new vaccine program will roll out in four phases. During the first, only residents in seniors supportive living and home care will be able to get a vaccine for free. The second phase will open provincially-funded COVID-19 vaccines to people with underlying medical conditions or compromised immune systems, people living in congregate living accommodations, people on social programs like AISH or income support or people experiencing homelessness. In the third and fourth phases, all other Albertans starting with those 65 years old or older will be able to purchase a vaccine. 'Cruel' Sarah Hoffman, Alberta NDP shadow minister for health, released a statement calling the decision 'callous' and 'anti-science.' 'It's cruel for the UCP government to put further financial burdens on Albertans who want to protect their health and their loved ones and not get COVID,' Hoffman said in the release. 'If the UCP government was really interested in eliminating waste and protecting the health of Albertans it would be promoting vaccines. That way the supply would get used and we would keep ourselves and our loved ones safe.' Wrong message Lorian Hardcastle, an associate professor at the University of Calgary's Faculty of Law and Cummings School of Medicine, said charging for COVID vaccines sends the wrong message to the public. 'It's problematic that we're switching to a model whereby most Albertans are going to have to pay for the vaccine rather than having it publicly-funded,' Hardcastle said. A container of syringes used to administer Novavax Covid-19 vaccines A container of syringes used to administer Novavax Covid-19 vaccines (Hannah Beier/Bloomberg) 'When we're talking about something that not only has ramifications for an individual, but for the community at large, COVID can affect the immunocompromised, the vulnerable,' she said. 'Of course, people who get COVID end up putting pressure on hospitals and so where individuals are getting vaccinated, not only for their own benefit, but for this public benefit, I think it's particularly imperative that the government pays for that.' She said the government's focus on the cost of wasted vaccines only tells half the story of what COVID can cost a provincial health care system. 'The Alberta government, in talking about the cost of the vaccine, needs to consider not only what they're spending on vaccinating people, but what they then save on the other end, in terms of avoidable hospitalizations, lost productivity -- all of these things, because the vaccine does also have financial benefits because it is preventative.' Cost: TBD Smith said the cost of a COVID vaccine hasn't been determined yet, but won't be as much as the RSV vaccine, which costs $300. One way to reduce costs, she said, will be to administer COVID vaccines at health clinics and not pharmacies. 'We want to make sure that those who want it can get it,' she said, 'but the best way to do it – and limit the cost (to taxpayers) – is to administer it through our public health centres, because we already have the staff there, so we don't have to pay a dispensing fee -- and we can negotiate as low a price as possible, which is what we're going to aim to do." She said the new COVID policy will reflect the province's approach to offering the RSV vaccine but at a lower cost. 'We only make the RSV vaccine available free to those most at risk – so we're taking the same kind of policy approach that we are for RSV and we'll gauge how many people sign up for it and then we'll make a decision if we have to change course in future years. 'But what we can't continue doing,' she added, 'is ordering an excessive number of doses that people don't want and then having them damaged, destroyed, spoiled and then going down the drain – and flushing that money. 'There's too many things we have to pay for in the health-care system and we've got to minimize the amount of wastage that we've got.' With files from CTV's Brittany Ekelund


Globe and Mail
2 hours ago
- Globe and Mail
From Scrubs to Coats: Zenir Introduces New White Lab Coat Collection for Healthcare Professionals
Zenir, the trusted name in premium medical scrubs, has officially expanded its product lineup with the launch of its first white lab coats available now for both men and women in short and long lengths. Torrance, California--(Newsfile Corp. - June 14, 2025) - Zenir, the trusted name in premium medical scrubs, has officially expanded its product lineup with the launch of its first white lab coats available now for both men and women in short and long lengths. Known for combining functional innovation with elevated style, Zenir continues to raise the standard for medical workwear with this new release. To view an enhanced version of this graphic, please visit: The newly launched white lab coats faithfully embody Zenir's philosophy of comfort, practicality, and refined style. The short-length lab coat is engineered with a three-dimensional pattern that naturally facilitates shoulder and arm movement ideal for dynamic, active roles while the long lab coat features a subtly cinched waistline and matte hidden snap buttons to deliver a sleek, professional silhouette in clinical settings. Meticulously designed storage details, such as a dedicated pen holder in the chest pocket and an inner pocket for smartphones, balance functionality with clean design. Optimized for fast-paced healthcare environments, this collection not only meets workplace requirements but also offers a range of fits and style options to suit every body shape and individual preference. Already recognized for its high-performance scrubs, Zenir is a brand trusted by thousands in the healthcare industry and has sold more than 3 million units globally. The brand has earned its reputation for premium-quality scrubs that are breathable, durable, wrinkle-resistant, and moisture-wicking, now extended to its latest line of white lab coats. As Zenir continues to grow its presence beyond Korea, this expansion into white lab coats marks a milestone in Zenir's commitment to offering a complete spectrum of medical workwear solutions. With thoughtfully tailored cuts, sustainable production using GRS-certified recycled fibers, and a design-first approach, Zenir's new white lab coats are built for professionals who expect more from their daily uniform. For more details, visit